These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26299618)

  • 1. CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination.
    Ravindranath AK; Kaur S; Wernyj RP; Kumaran MN; Miletti-Gonzalez KE; Chan R; Lim E; Madura K; Rodriguez-Rodriguez L
    Oncotarget; 2015 Sep; 6(28):26308-21. PubMed ID: 26299618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO15 regulates P-glycoprotein/ABCB1 expression through the ubiquitin--proteasome pathway in cancer cells.
    Katayama K; Noguchi K; Sugimoto Y
    Cancer Sci; 2013 Jun; 104(6):694-702. PubMed ID: 23465077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSK1 protects P-glycoprotein/ABCB1 against ubiquitin-proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1.
    Katayama K; Fujiwara C; Noguchi K; Sugimoto Y
    Sci Rep; 2016 Oct; 6():36134. PubMed ID: 27786305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCF E3 ligase F-box protein complex SCF(FBXL19) regulates cell migration by mediating Rac1 ubiquitination and degradation.
    Zhao J; Mialki RK; Wei J; Coon TA; Zou C; Chen BB; Mallampalli RK; Zhao Y
    FASEB J; 2013 Jul; 27(7):2611-9. PubMed ID: 23512198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.
    Zhang Y; Qu X; Teng Y; Li Z; Xu L; Liu J; Ma Y; Fan Y; Li C; Liu S; Wang Z; Hu X; Zhang J; Liu Y
    Oncotarget; 2015 Mar; 6(9):6737-48. PubMed ID: 25788263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXO21 mediates the ubiquitylation and proteasomal degradation of EID1.
    Watanabe K; Yumimoto K; Nakayama KI
    Genes Cells; 2015 Aug; 20(8):667-74. PubMed ID: 26085330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
    Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
    J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells.
    Pokharel D; Padula MP; Lu JF; Jaiswal R; Djordjevic SP; Bebawy M
    Molecules; 2016 Mar; 21(3):290. PubMed ID: 26938523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2.
    Wei J; Mialki RK; Dong S; Khoo A; Mallampalli RK; Zhao Y; Zhao J
    Biochim Biophys Acta; 2013 Dec; 1833(12):2757-2764. PubMed ID: 23871831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation.
    Viñas-Castells R; Beltran M; Valls G; Gómez I; García JM; Montserrat-Sentís B; Baulida J; Bonilla F; de Herreros AG; Díaz VM
    J Biol Chem; 2010 Feb; 285(6):3794-3805. PubMed ID: 19955572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro.
    Yan YY; Wang F; Zhao XQ; Wang XK; Chen YF; Liu H; Xie Y; Fu LW
    Oncol Rep; 2017 Jan; 37(1):31-40. PubMed ID: 27840996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy.
    Foran E; Kwon DY; Nofziger JH; Arnold ES; Hall MD; Fischbeck KH; Burnett BG
    Neurobiol Dis; 2016 Apr; 88():118-24. PubMed ID: 26792401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins.
    Pavlikova L; Seres M; Hano M; Bohacova V; Sevcikova I; Kyca T; Breier A; Sulova Z
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28671633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-box protein Fbxo3 targets Smurf1 ubiquitin ligase for ubiquitination and degradation.
    Li D; Xie P; Zhao F; Shu J; Li L; Zhan Y; Zhang L
    Biochem Biophys Res Commun; 2015 Mar; 458(4):941-5. PubMed ID: 25721664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an
    Negi LM; Talegaonkar S; Jaggi M; Verma AK
    J Drug Target; 2019 Feb; 27(2):183-192. PubMed ID: 29972336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis.
    Wittorf KJ; Weber KK; Swenson SA; Buckley SM
    Exp Hematol; 2022 Oct; 114():33-42.e3. PubMed ID: 35987460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBW2 targets GCMa to the ubiquitin-proteasome degradation system.
    Yang CS; Yu C; Chuang HC; Chang CW; Chang GD; Yao TP; Chen H
    J Biol Chem; 2005 Mar; 280(11):10083-90. PubMed ID: 15640526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.